If scale economies are present and the size of the operation is unmeasured, this increase in size of managed care organizations would lead to an overestimate of learning effects. Similarly, technological improvements in either treatment shift to medications or care management that are generally available and not internal to an organization could give
rise to an organizational learning effect unless one controls for their existence.